July 10, 2020
Shionogi’s anti-flu drug Xofluza (baloxavir marboxil) significantly reduced the proportion of household contacts that developed clinical influenza in a Japan PIII study evaluating the drug as a post-exposure prophylaxis treatment, the company said on July 9. The drug was also...read more